Back to results
US 7,608,577 B2Granted
Peptidyl ketones as inhibitors of DPIV
AssigneeOSI Pharmaceuticals, Inc.
InventorsUlrich Heiser, André Johannes Niestroj, Torsten Hoffmann, Hans-Ulrich Demuth
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of the general formula 1 and pharmaceutically acceptable salts thereof, to the use of the compounds for the treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidosis, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus in mammals.
Claims5
A compound formula 1:
- or a pharmaceutically acceptable salts thereof, wherein:
- A is selected from:
- wherein
- X1 is H or an amino acid residue, a N-protected amino acid residue, a peptide residue or a N-protected peptide residue,
- X2 is H, —(CH)m—NH—C5H3N—Y with m=2-4, or —C5H3N—Y (a divalent pyridyl residue) and Y is selected from H, Br, Cl, I, NO2 and CN,
- X3 is H or an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted phenyl or from an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted pyridyl residue,
- X4 is H or an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted phenyl or an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted pyridyl residue,
- X5 is H or an alkyl, alkoxy or phenyl residue,
- X6 is H or an alkyl residue,
- for n=1
- X is selected from OR2 and SR2, wherein:
- R2 is an acyl residues, optionally substituted with alkyl, cycloalkyl, aryl or heteroaryl residues, or an amino acid residue or peptidic residue, or alkyl residue, which are optionally substituted with alkyl, cycloalkyl, aryl or heteroaryl residues,
- for n=0
- X is selected from:
- wherein
- B is O, S or NR5, wherein R5 is H, alkyl or acyl,
- C, D, E, F, G, Y, K, L, M, Q, T, U, V and W are independently selected from alkyl and substituted alkyl residues, oxyalkyl, thioalkyl, aminoalkyl, carbonylalkyl, acyl, carbamoyl, aryl and heteroaryl residues, and
- Z is H, or a branched or straight chain alkyl residue from C1-C9, a branched or straight chain alkenyl residue from C2-C9, a cycloalkyl residue from C3-C8, a cycloalkenyl residue from C5-C7, an aryl or heteroaryl residue, or a side chain selected from all side chains of all natural amino acids or derivatives thereof.
15 more elements
A compound selected from the group consisting of
- 2-methylcarbonyl-1-N-[(L)-Alanyl-(L)-Valinyl]-(2S)-pyrrolidine hydrobromide;
- 2-methylcarbonyl-1-N-[(L)-Valinyl-(L)-Prolyl-(L)-Valinyl]-(2S)-pyrrolidine hydrobromide;
- 2-[(acetyloxy-methyl)carbonyl]-1-N-[(L)-Alanyl-(L)-Valinyl]-(2S)-pyrrolidine hydrobromide;
- 2-[(benzoyloxy-methyl)carbonyl]-1-N-[{(L)-Alanyl}-(L)-Valinyl]-(2S) -pyrrolidine hydrobromide;
- 2-{[(2,6-dichlorobenzyl)thiomethyl]carbonyl}-1-N-[{(L)-Alanyl}-(L)-Valinyl]-(2S)-pyrrolidine;
- 2-[(benzoyloxy-methyl)carbonyl]-1-N-[Glycyl-(L)-Valinyl]-(2S)-pyrrolidine hydrobromide;
- 2-[([1,3]-thiazol-2-yl)carbonyl]-1-N-[{(L)-Alanyl}-(L)-Valinyl]-(2S)-pyrrolidine trifluoracetate;
- 2-[(benzothiazol-2-yl)carbonyl]-1-N-[{(L-Alanyl}-(L)-Valinyl]-(2S)-pyrrolidine trifluoracetate;
- 2-[(-benzothiazol-2-yl)carbonyl]-1-N-[{(L)-Alanyl}-Glycyl]-(2S)-pyrrolidine trifluoracetate;
- and
- 2-[(pyridin-2-yl)carbonyl]-1-N[{(L)-Alanyl}-(L)-Valinyl]-(2S)-pyrrolidine trifluoracetate.
8 more elements
A compound of formula 1:
- or a pharmaceutically acceptable salt thereof, wherein A is:
- wherein
- n=0
- X1 is H or an amino acid residue, an N-acylated amino acid residue, or a dipeptide residue containing a Pro or Ala in the penultimate position, or an N-protected dipeptide residue containing a Pro or Ala in the penultimate position,
- X is selected from:
- wherein
- B is O, C, D, E, F, G, Y, K, L, M and Q are H,
- Z is H, or a branched or straight chain alkyl residue from C3-C5, a branched or straight chain alkenyl residue from C2-C9, a cycloalkyl residue from C5-C7, a cycloalkenyl residue from C5-C7, an aryl or heteroaryl residue, or a side chain selected from all side chains of all natural amino acids or derivatives thereof.
5 more elements
Dependencies are inferred from the claim text.